INSIGHTS
CONTACT
INSIGHTS
CONTACT
INSIGHTS
CONTACT
INSIGHTS
CONTACT
INSIGHTS
CONTACT
Uniting biotech, web3 and
longevity into modern health.
Garri Zmudze is a renowned expert in
transformative health technologies.
Featured in:
Meet
Garri
Meet
Garri
Garri Zmudze invests in and advises deeptech companies.
He is building a sector-wide movement for well-being and longevity.
Garri is dedicated to a future where humans have more healthy, fulfilling years with their loved ones. 
In service of this mission, in 2021 he co-founded the Longevity Science Foundation, a global nonprofit funding early-stage research on extending the healthy human lifespan.
Garri is also the managing partner and co-founder of LongeVC, a venture capital firm investing in visionary biotech and longevity.
01
BOARD MEMBER
Garri has also embraced a new opportunity to extend his impact by joining as an executive board member at the Sheba Longevity Center, contributing to their pioneering efforts in longevity research and innovation.
02
INVESTOR & ADVISOR
Garri also joins promising startups as an advisor and angel investor, with several successful exits across biotech and emerging tech companies, including Insilico Medicine, Deep Longevity, and Basepaws.
01
INDUSTRY EXPERT
He is sought-after for his biotech and web3 experience, advising enterprises like Cointelegraph, PsyMed Ventures, the Healthy Longevity Medicine Society, and more. He is also a member of the Longevity Biotechnology Association.
"Modern health is about well-being.
Technology will deliver transformation that impacts all aspects of our lives."
Technology has been used to improve our healthcare for decades. Now, it is key to the discovery and development of well-being - the next great frontier of health science.
Well-being is a health approach that cares about curing illness and preserving wellness. It integrates technology like AI, longevity, web3, biotech and others to create a more equitable and accessible healthcare system.
Technology will redefine how individuals experience medical interventions and monitor their daily well-being.
We cannot pursue a new approach to health alone. It requires collaboration between founders, investors, researchers, patients, and more.
Garri’s singular focus is to back companies, nonprofits, and researchers pursuing
this modern health approach, working with dozens of well-recognized enterprises around the globe.
Angel Investor
Founder
LongeVC & AniVC Investments
Advisor / Member
INSIGHTS FROM GARRI
Garri contributes to top media outlets, events, and journals worldwide.
POST - January 30, 2025
LongeVC’s Q3 & Q4 2024: Investments and Portfolio Updates
LongeVC shares Q3 & Q4 2024 updates, including new investments in Glyphic Bio and Proton Intelligence, as well as key portfolio developments from Turn Bio and Longenesis.
POST - May 29, 2024
FinanceAsia: Deals Ramp Up in Asia’s Healthcare Space with Cancer Focus
Garri Zmudze discussed the cancer treatment sector in Asia, its landscape, and its potential with Andrew Tjaardstra from Finance Asia during his recent visit to Hong Kong.
POST - june 06, 2024
Summary of LongeVC’s Investments in Q1 and Q2
As we’re getting to the end of Q2, we prepared a quick summary of all the new additions to LongeVC’s investment portfolio.
See all insights
Let's build the future
of our health, together.
Get in touch
About
Insights
0%